PMID- 22928864 OWN - NLM STAT- MEDLINE DCOM- 20130702 LR - 20220129 IS - 1476-5381 (Electronic) IS - 0007-1188 (Print) IS - 0007-1188 (Linking) VI - 168 IP - 3 DP - 2013 Feb TI - 4alpha-phorbol 12,13-didecanoate activates cultured mouse dorsal root ganglia neurons independently of TRPV4. PG - 761-72 LID - 10.1111/j.1476-5381.2012.02186.x [doi] AB - BACKGROUND AND PURPOSE: The Ca(2+) -permeable cation channel TRPV4 is activated by mechanical disturbance of the cell membrane and is implicated in mechanical hyperalgesia. Nerve growth factor (NGF) is increased during inflammation and causes mechanical hyperalgesia. 4alpha-phorbol 12,13-didecanoate (4alphaPDD) has been described as a selective TRPV4 agonist. We investigated NGF-induced hyperalgesia in TRPV4 wild-type (+/+) and knockout (-/-) mice, and the increases in [Ca(2+) ](i) produced by 4alphaPDD in cultured mouse dorsal root ganglia neurons following exposure to NGF. EXPERIMENTAL APPROACH: Withdrawal thresholds to heat, von Frey hairs and pressure were measured in mice before and after systemic administration of NGF. Changes in intracellular Ca(2+) concentration were measured by ratiometric imaging with Fura-2 in cultured DRG and trigeminal ganglia (TG) neurons during perfusion of TRPV4 agonists. KEY RESULTS: Administration of NGF caused a significant sensitization to heat and von Frey stimuli in TRPV4 +/+ and -/- mice, but only TRPV4 +/+ mice showed sensitization to noxious pressure. 4alphaPDD stimulated a dose-dependent increase in [Ca(2+) ](i) in neurons from +/+ and -/- mice, with the proportion of responding neurons and magnitude of increase unaffected by the genotype. In contrast, the selective TRPV4 agonist GSK1016790A failed to stimulate an increase in intracellular Ca(2+) in cultured neurons. Responses to 4alphaPDD were unaffected by pretreatment with NGF. CONCLUSIONS AND IMPLICATIONS: TRPV4 contributes to mechanosensation in vivo, but there is little evidence for functional TRPV4 in cultured DRG and TG neurons. We conclude that 4alphaPDD activates these neurons independently of TRPV4, so it is not appropriate to refer to 4alphaPDD as a selective TRPV4 agonist. CI - (c) 2012 The Authors. British Journal of Pharmacology (c) 2012 The British Pharmacological Society. FAU - Alexander, R AU - Alexander R AD - Wolfson Centre for Age-Related Diseases, King's College London, London, UK. FAU - Kerby, A AU - Kerby A FAU - Aubdool, A A AU - Aubdool AA FAU - Power, A R AU - Power AR FAU - Grover, S AU - Grover S FAU - Gentry, C AU - Gentry C FAU - Grant, A D AU - Grant AD LA - eng GR - BB/E527098/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Br J Pharmacol JT - British journal of pharmacology JID - 7502536 RN - 0 (Phorbol Esters) RN - 0 (TRPV Cation Channels) RN - 0 (Trpv4 protein, mouse) RN - 24928-17-4 (phorbol-12,13-didecanoate) RN - 9061-61-4 (Nerve Growth Factor) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Calcium/physiology MH - Cell Line MH - Cells, Cultured MH - Female MH - Ganglia, Spinal/cytology MH - Humans MH - Hyperalgesia/*physiopathology MH - Male MH - Mice MH - Mice, Knockout MH - Nerve Growth Factor/pharmacology MH - Neurons/*drug effects/physiology MH - Phorbol Esters/*pharmacology MH - TRPV Cation Channels/*physiology MH - Trigeminal Ganglion/cytology PMC - PMC3579293 EDAT- 2012/08/30 06:00 MHDA- 2013/07/03 06:00 PMCR- 2014/02/01 CRDT- 2012/08/30 06:00 PHST- 2012/03/21 00:00 [received] PHST- 2012/07/22 00:00 [revised] PHST- 2012/08/15 00:00 [accepted] PHST- 2012/08/30 06:00 [entrez] PHST- 2012/08/30 06:00 [pubmed] PHST- 2013/07/03 06:00 [medline] PHST- 2014/02/01 00:00 [pmc-release] AID - 10.1111/j.1476-5381.2012.02186.x [doi] PST - ppublish SO - Br J Pharmacol. 2013 Feb;168(3):761-72. doi: 10.1111/j.1476-5381.2012.02186.x.